On Tuesday, Pfizer reported another quarter of enormous revenue growth thanks to the COVID-19 vaccine, but it cut its full-year profit prediction due to foreign exchange fluctuations. The large American pharmaceutical company posted first-quarter revenue of $25.7 billion, up 77 percent from the previous quarter, with the COVID vaccine bringing in $13.2 billion. Pfizer now expects adjusted profits of $6.25 to $6.45 per share for the full year, down 10 cents from the previous forecast.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week